Centese logo

Centese Funding & Investors

Omaha, NE

Centese is a medical device company that develops Thoraguard, a reliable surgical drainage system. Using digital intelligence, Thoraguard revolutionizes operative drainage in cardiothoracic surgery. Thoraguard is a digital technology that provides accurate data monitoring and automatic chest tube clearing with the goal of enhancing clinical judgment and patient safety. Centese is committed to delivering improved post-operative surgical drainage solutions that are designed for safety, intelligence, and effectiveness in order to enhance results and save costs in cardiothoracic surgery.

centese.com

Total Amount Raised: $21,489,998

Centese Funding Rounds

  • Series B

    $15,000,000

    Series B Investors

    MedTech Venture Partners
  • Series A

    $2,000,000

    Series A Investors

    Invest Nebraska
  • Series A

    $2,900,000

  • Grant

    $1,409,999

    Grant Investors

    National Science Foundation (NSF)
  • Grant

    $179,999

    Grant Investors

    National Science Foundation (NSF)
Funding info provided by Diffbot.